Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IDL Diagnostics ABOSTO:IDLDX +3.69%55 Days Inventory is 113.12 as of Mar. 2026, which is 27% above its 10-year median of 89.24. GuruFocus rates OSTO:IDLDX with a GF Score™ of 55/100 and a GF Value™ of kr0.54 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 179 Medical Diagnostics & Research companies, IDL Diagnostics AB ranks worse than 59.22% on this metric.
The historical rank and industry rank for IDL Diagnostics AB's Days Inventory or its related term are showing as below:
OSTO:IDLDX'
s Days Inventory Range Over the Past 10 Years
Min: 54.36 Med: 89.24 Max: 25211.07
Current: 82.88
During the past 13 years, IDL Diagnostics AB's highest Days Inventory was 25211.07. The lowest was 54.36. And the median was 89.24.
OSTO:IDLDX's Days Inventory is ranked worse than 59.22% of 179
companies
in the Medical Diagnostics & Research industry
Industry Median: 65.04
vs OSTO:IDLDX: 82.88
IDL Diagnostics AB's Days Inventory
increased
from Mar. 2025 (76.19) to Mar. 2026 (113.12).
It might indicate that IDL Diagnostics AB's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
IDL Diagnostics AB's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.81.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
IDL Diagnostics AB's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.43.
IDL Diagnostics AB (OSTO:IDLDX) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
IDL Diagnostics AB's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
IDL Diagnostics AB's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
IDL Diagnostics AB Days Inventory Related Terms
IDL Diagnostics AB Days Inventory Historical Data
* Premium members only.
The historical data trend for IDL Diagnostics AB's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:IDLDX vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, IDL Diagnostics AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDL Diagnostics AB Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, IDL Diagnostics AB's Days Inventory distribution charts can be found below:
* The bar in red indicates where IDL Diagnostics AB's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDL Diagnostics AB (OSTO:IDLDX) has a Days Inventory of 113.12 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on IDL Diagnostics AB and its competitors. This is 27% above median its historical median of 89.24. Over the past decade, IDL Diagnostics AB's Days Inventory has ranged from 54.36 to 25,211.07. According to the industry distribution chart, IDL Diagnostics AB ranks #106 out of 179 companies in the Medical Diagnostics & Research industry, placing it in the top 59.2%.
Is IDL Diagnostics AB's Days Inventory too high?
IDL Diagnostics AB's current Days Inventory of 113.12 is 27% above median its 10-year median of 89.24. Over the past 10 years, this metric has ranged from a low of 54.36 to a high of 25,211.07. The Medical Diagnostics & Research industry median Days Inventory is 65.04. IDL Diagnostics AB's value of 113.12 is 73.9% above this industry median. Based on the distribution chart, IDL Diagnostics AB ranks #106 out of 179 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, IDL Diagnostics AB has a GF Score™ of 55/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IDL Diagnostics AB's Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, IDL Diagnostics AB ranks #106 out of 179 companies for Days Inventory. This places IDL Diagnostics AB in the lower half of its industry. The industry median Days Inventory is 65.04. IDL Diagnostics AB's value of 113.12 is 73.9% above this benchmark. Historically, IDL Diagnostics AB's own Days Inventory has ranged from 54.36 to 25,211.07 over the past decade. While the company's 10-year median is 89.24 vs. the industry median of 65.04, IDL Diagnostics AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 65.04, based on 179 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IDL Diagnostics AB's current Days Inventory of 113.12 is 73.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on IDL Diagnostics AB and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 65.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IDL Diagnostics AB's current Days Inventory is 113.12, which is 27% above median its own 10-year median of 89.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDL Diagnostics AB stock overvalued right now?
Based on GuruFocus' analysis, IDL Diagnostics AB (OSTO:IDLDX) is currently considered Modestly Undervalued. The stock's GF Value™ is kr0.54, compared to a current price of kr0.42 — trading 21.9% below its estimated fair value. The current Days Inventory is 113.12, which is 27% above median its 10-year median of 89.24 and 73.9% above the Medical Diagnostics & Research industry median of 65.04. IDL Diagnostics AB's overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For IDL Diagnostics AB (OSTO:IDLDX), the current Days Inventory is 113.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IDL Diagnostics AB (OSTO:IDLDX) Overvalued in 2026?
Based on GuruFocus' analysis, IDL Diagnostics AB stock appears to be undervalued.
The current stock price of kr0.42 is trading 21.9% below its estimated GF Value™ of kr0.54.
GuruFocus considers IDL Diagnostics AB to be Modestly Undervalued.
Key valuation signals for OSTO:IDLDX:
Days Inventory: 113.12 (27% above median its 10-year median of 89.24)
GF Value™: kr0.54 vs. price of kr0.42 (21.9% below fair value)
Industry Position: 73.9% above the Medical Diagnostics & Research median (#106 of 179)
No single metric tells the full story. See the OSTO:IDLDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IDL Diagnostics AB is a Swedish company that develops and markets blood and urine sample tests. It specializes in oncology and bacteriology. The company has a broad product portfolio, is used in healthcare, and is established in various markets. In oncology, IDL Diagnostics uses various biomarkers, TK1 and cytokeratins, to support the treatment of cancers such as breast, prostate, and bladder cancers.
55GF Score
Get the complete analysis for OSTO:IDLDX
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:IDLDX has been successfully added to your 
